Showing results (41-50 of 112) with videos related to
Sort By:
Pageof 12
Swiss Medical Weekly|April 25, 2006
Reliability and validity of a German asthma quality of life questionnaireDavid Miedinger, Prashant N Chhajed, Daiana Stolz, et al.Respiratory Research|August 15, 2021
Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trialSeverin Vogt, Jörg D Leuppi, Philipp Schuetz, et al.Swiss Medical Weekly|December 3, 2005
Diagnostic value of lung auscultation in an emergency room settingJörg D Leuppi, Thomas Dieterle, Gian Koch, et al.Respiratory Medicine|June 21, 2005
Can airway obstruction be estimated by lung auscultation in an emergency room setting?Jörg D Leuppi, Thomas Dieterle, Irène Wildeisen, et al.Sleep Medicine Reviews|May 25, 2013
Sleep problems and work injuries: a systematic review and meta-analysisKatrin Uehli, Amar J Mehta, David Miedinger, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 27, 2016
The integrated care of asthma in Switzerland (INCAS)-study: Patients' perspective of received asthma care and their interest in asthma educationSelina Dürr, Kurt E Hersberger, Andreas Zeller, et al.Contemporary Clinical Trials Communications|September 6, 2021
Point of care with serial NT-proBNP measurement in patients with acute decompensated heart failure as a therapy-monitoring during hospitalization (POC-HF): Study protocol of a prospective, unblinded, randomized, controlled pilot trialStephanie Züsli, Frederick Bierreth, Maria Boesing, et al.Journal of Clinical Medicine|September 14, 2024
Proteinuria Assessment and Therapeutic Implementation in Chronic Kidney Disease Patients-A Clinical Audit on KDIGO ("Kidney Disease: Improving Global Outcomes") GuidelinesGabriela Adelakun, Maria Boesing, Munachimso Kizito Mbata, et al.Praxis|May 29, 2019
[Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic Asthma]Jörg D Leuppi, Peter Schmid-Grendelmeier, Thomas Rothe, et al.Praxis|May 29, 2019
[Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic Asthma]Jörg D Leuppi, Peter Schmid-Grendelmeier, Thomas Rothe, et al.Pageof 12